Purdue Pharma L.P.

Type: Company
Name: Purdue Pharma L.P. (Purdue Pharma L.P)
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Monday Moves: September 15

Share this article:MANUFACTURERPurdue Pharma announced that  Susie Robinson , former head of human resources at Lumeris, has joined the company as Vice President of Human Resources. Prior to Lumeris, Robinson was the chief human resources officer at Infogroup, ... [Published Medical Marketing And Media - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 2 reports

Purdue Pharma L.P. Names Susie Robinson Vice President of Human Resources

STAMFORD, Conn., Sept. 15, 2014 /PRNewswire/ -- Purdue Pharma L.P. today announced that Susie Robinson, former head of human resources at Lumeris, has joined the company as Vice President of Human Resources. "With her proven record of transforming organizations ... [Published TickerTech.com - Sep 15 2014]
First reported Sep 14 2014 - Updated Sep 14 2014 - 1 reports

Ex-cops screening patients at pain pill clinics

Some West Virginia pain clinics are using former narcotics officers to screen patients – and charging people $150 for the service.A representative of the contractor that hires the officers — called “narcotics auditors” — told state lawmakers last week ... [Published Charleston Gazette - Sep 14 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Purdue Pharma announces results from pain studies and post-hoc analyses

Purdue Pharma L.P., a provider of prescription and over-the-counter medicines, has announced results from several studies and post-hoc analyses evaluating extended-release, single-entity hydrocodone bitartrate tablets, including the analgesic effectiveness ... [Published Individual.com - Sep 12 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Higher Authorities? - Pharmaceutical Companies, Addiction Experts, and Marijuana Policy

We have often discussed the web of conflicts of interest that is draped over medicine and health care, and seems responsible for much of our current health care dysfunction.  We have discussed examples of conflicts of interest affecting clinical research, ... [Published Health Care Renewal - Sep 11 2014]
Entities: Addiction, anodyne, Opioid
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Businesses hear benefits of carrying CEAS card

A disaster in a community could jeopardize the future of a business when it prevents an owner or essential staff from retrieving essential information or material or addressing concerns about equipment and machinery up close.Working with local businesses, ... [Published Stamford Advocate - Sep 11 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Purdue Pharma submits NDA for pain drug to FDA

Purdue Pharma L.P., a provider of prescription and over-the-counter medicines, has submitted a new drug application, or NDA, to the FDA for an immediate-release oxycodone HCl formulation, designed with the intent to deter intranasal and intravenous abuse ... [Published Individual.com - Sep 10 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 2 reports

Anti-Marijuana Academics Paid By Big Pharma

In a clear conflict of interest, a new report from VICE has revealed that several academic researchers who have spoken out against legalizing marijuana are being paid by pharmaceutical companies that make painkiller products.Dr. Herbet Kleber of Columbia ... [Published Fix.com - Sep 09 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Blood cancer research expert to speak at UOIT September 30 - September 08, 2014

Dr. Aaron Schimmer to present 2014 Purdue Pharma Canada Distinguished LectureThe Faculty of Science will welcome Dr. Aaron Schimmer to campus on Tuesday, September 30 to present the seventh-annual Purdue Pharma Canada Distinguished Lecture, entitled: ... [Published Noodls - Sep 08 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Purdue Pharma: Abuse rates of OxyContin significantly down three years after reformulation

September 5, 2014STAMFORD, Conn. — Purdue Pharma on Thursday presented results from two epidemiological studies evaluating the reformulation of OxyContin, which occurred in 2010, that showed a marked decrease in rates of abuse, addiction and poisoning ... [Published Drug Store News - Sep 05 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

Purdue Pharma Presents Educational Session on Abuse-Deterrent Technology and Opioid Analgesics at PAINWeek

Purdue Pharma News and Media Purdue Pharma’s Vice President of Health Policy, Dr. J. David Haddox, will present an educational session today at PAINWeek’s annual conference, entitled:Innovative Formulations Designed to Deter the Abuse of Opioid Analg ... [Published Purdue - Sep 04 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 2 reports

New Research Highlights an Investigational Single-Entity Formulation Hydrocodone Bitartrate Extended-Release Tablet at PAINWeek

STAMFORD, Conn.Purdue Pharma's investigational pain medication, once-daily hydrocodone bitartrate (which is expected to be marketed under the trade name, Hysingla™ ER) is a single-entity product that does not include acetaminophen. The tablets are formulated ... [Published Stock Nod - Sep 04 2014]

Quotes

Sponsored by: "It is an incredible honor for me to head the people function at Purdue," said Robinson. "The company has a culture strong in tradition and innovation and a mission of serving patients and customers to make the world a better place."
"These studies continue to support the fact that, if approved by the Food and Drug Administration, Hysingla ER could be an important alternative for healthcare professionals treating patients in chronic pain with a hydrocodone product formulated with physicochemical properties intended to deter abuse" said Todd Baumgartner, M D , MPH, vice president of R&D and Chief Medical Officer at Purdue Pharma which funded the research
This is hardly the first time that medical corporations have been caught putting profits ahead of healing. "Big Pharma and Health Care: Unsolvable Conflict of Interests Between Private Enterprise and Public Health" a 2008 study of pharmaceutical company practices, found all kinds of problems, including sophisticated but questionable marketing techniques, companies...
...  Others, of course, do not agree.Now Vice News, which advertises itself as "an international news organization created by and for a connected generation" has published an article by investigative journalist Lee Fang about conflicts of interest, key opinion leaders, and marijuana policy...

More Content

All (83) | News (51) | Reports (0) | Blogs (30) | Audio/Video (0) | Fact Sheets (1) | Press Releases (1)
sort by: Date | Relevance
Monday Moves: September 15 [Published Medical Marketing And Media - Sep 15 2014]
Purdue Pharma L.P. Names Susie Robinson Vice Pr... [Published TickerTech.com - Sep 15 2014]
Purdue Pharma L.P. Names Susie Robinson Vice Pr... [Published PR Newswire: Financial Services - Sep 15 2014]
Ex-cops screening patients at pain pill clinics [Published Charleston Gazette - Sep 14 2014]
Purdue Pharma announces results from pain studi... [Published Individual.com - Sep 12 2014]
Opioids, Cannabis, Scientists and Money, Lots [Published Media Awareness Project - Sep 12 2014]
Higher Authorities? - Pharmaceutical Companies,... [Published Health Care Renewal - Sep 11 2014]
Businesses hear benefits of carrying CEAS card [Published Stamford Advocate - Sep 11 2014]
Purdue Pharma submits NDA for pain drug to FDA [Published Individual.com - Sep 10 2014]
Pain and Depression Treatment Possible in Fibro... [Published Diabetes Care - Sep 09 2014]
Anti-Marijuana Academics Paid By Big Pharma [Published Fix.com - Sep 09 2014]
Leading Anti-Marijuana Advocates Are Being Priv... [Published Inquisitr - Sep 09 2014]
Blood cancer research expert to speak at UOIT S... [Published Noodls - Sep 08 2014]
The Changing Face of Opioid Addiction [Published General Medicine eJournal - Sep 08 2014]
Purdue Pharma: Abuse rates of OxyContin signifi... [Published Drug Store News - Sep 05 2014]
Purdue Pharma Presents Educational Session on A... [Published Purdue - Sep 04 2014]
New Research Highlights an Investigational Sing... [Published Stock Nod - Sep 04 2014]
New Research Highlights an Investigational Sing... [Published PR Newswire: General Business - Sep 04 2014]
Longer Looks: Alzheimer's And A Marriage; Racis... [Published Capital Times - Sep 04 2014]
How Big Pharma Is Sandbagging Marijuana [Published High Times - Sep 03 2014]
The case for and against RFID in pharma [Published Packaging World - Sep 03 2014]
Anti-Pot critics paid by drug companies [Published Ebony - Sep 02 2014]
BigPharma manufacturers of addictive painkiller... [Published Sott.net - Sep 01 2014]
Opioid epidemic: Abuse-deterrent opioids the an... [Published Pharmacist.com - Sep 01 2014]
Florida heals from pill mill epidemic [Published Tampa Tribune - Aug 31 2014]
Letter: Marijuana legislation is all about profit [Published Rockford Register Star - Aug 31 2014]
Early users found VSAN hardware difficult, mana... [Published SearchVirtualStorage - Aug 29 2014]
Hiring gains momentum [Published Insurance News Net - Aug 29 2014]
Pharma Startup Kolltan Raises $5M [Published Connecticut Business News Journal - Aug 29 2014]
25 Percent of California Foster Teens are Drugg... [Published Opposing Views - Aug 29 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Purdue Pharma L.P. Names Susie Robinson Vice Pr... [Published PR Newswire: Financial Services - Sep 15 2014]
STAMFORD, Conn., Sept. 15, 2014 /PRNewswire/ -- Purdue Pharma L.P. today announced that Susie Robinson, former head of human resources at Lumeris, has joined the company as Vice President of Human Resources. "With her proven record of transforming ...
Higher Authorities? - Pharmaceutical Companies,... [Published Health Care Renewal - Sep 11 2014]
We have often discussed the web of conflicts of interest that is draped over medicine and health care, and seems responsible for much of our current health care dysfunction.  We have discussed examples of conflicts of interest affecting clinical research, ...
New Research Highlights an Investigational Sing... [Published PR Newswire: General Business - Sep 04 2014]
STAMFORD, Conn., Sept. 4, 2014 /PRNewswire/ -- Purdue Pharma is presenting results from several studies and post-hoc analyses evaluating extended-release, single-entity hydrocodone bitartrate tablets, including the analgesic effectiveness and safety ...
Purdue Pharma gets FDA approval for 7.5 mcg/hou... [Published PBR - News - Jul 21 2014]
Purdue Pharma has announced that the US Food & Drug Administration (FDA) has approved a new 7.5 mcg/hour dosage strength of Butrans (buprenorphine) Transdermal System CIII. Five strengths of Butrans will now be available: 5 mcg/hour, 7.5 mcg/hour, 10 ...
Purdue Pharma L.P. Receives FDA Approval for 7.... [Published PR Newswire: Policy & Public Interest - Jul 16 2014]
STAMFORD, Conn., July 16, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food & Drug Administration (FDA) approved a new 7.5 mcg/hour dosage strength of Butrans® (buprenorphine) Transdermal System CIII. Five strengths of Butrans will ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Purdue Pharma L.P., a Leading Pharmaceutical Co... [Published Financial Services - Jun 18 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.